Fig. 6From: Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patientsImpact of ToxNav on factors related to depression (as measured by the PHQ-8)Back to article page